跳至主要内容
临床试验/ISRCTN52491619
ISRCTN52491619已完成不适用

A prospective randomised study comparing 'standard open' haemorrhoidectomy with the 'completely closed and sutured' technique.

Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)0 个研究点目标入组 40 人开始时间: 2005年9月30日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Not provided at time of registration

排除标准

  • Not provided at time of registration

研究者

发起方
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)

相似试验

尚未招募
4 期
Comparison of two techniques of LMA insertion in paediatric population (standard and reverse technique)
CTRI/2023/12/060734ttar pradesh university of medical sceinces saifai etawah
招募中
不适用
A prospective randomised comparative study on the use of panoramic radiograph and cone beam scan with respect to the outcomes and incidence of inferior alveolar nerve injury after lower third molar removal, and establishing guidelines for the indications of cone beam scan as an adjunct to panoramic radiographsImpacted Wisdom teethInferior Alveolar Nerve injury after third molar removalOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
ACTRN12610000638033Royal Dental Hospital Melbourne4,000
进行中(未招募)
3 期
A Comparative study for the efficacy and side effects in subcutaneous and oral methotrexate in patients of chronic plaque psoriasis.
CTRI/2020/07/026598Ishan Agrawal
招募中
不适用
Comparing level of sensory blockade with intrathecal isobaric Ropivacaine injection in sitting position v/s in lateral position.
CTRI/2017/05/008604A60
进行中(未招募)
1 期
A prospective randomised study to compare a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 25 mg with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg in patients with uncontrolled hypertension who fail to respond adequately to treatment with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg.
EUCTR2005-002442-19-FIBoehringer Ingelheim Finland Ky1,600